Humanized non-human animals with restricted immunoglobulin heavy chain loci
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsLynn Macdonald, John McWhirter, Sean Stevens, Andrew J. Murphy
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsLynn Macdonald, John McWhirter, Sean Stevens, Andrew J. Murphy
Estimating the term…
Mice, embryos, cells, and tissues having a restricted immunoglobulin heavy chain locus and an ectopic sequence encoding one or more ADAM6 proteins are provided. In various embodiments, mice are described that have humanized endogenous immunoglobulin heavy chain loci and are capable of expressing an ADAM6 protein or ortholog or homolog or functional fragment thereof that is functional in a male mouse. Mice, embryos, cells, and tissues having an immunoglobulin heavy chain locus characterized by a single human VH gene segment, a plurality of human DH gene segments and a plurality of human JH gene segments and capable expressing an ADAM6 protein or ortholog or homolog or functional fragment thereof are also provided.
A male mouse having in its germline:
A male mouse comprising an insertion including an unrearranged human genomic sequence including a single human VH gene segment operably linked to at least one human DH gene segment, and at least one human JH gene segment, wherein the single human VH gene segment, the at least one human DH gene segment, and the at least one JH gene segment are operably linked to a mouse immunoglobulin constant region gene at the endogenous immunoglobulin heavy chain locus, wherein the single human VH gene segment is VH1-69 or a polymorphic variant thereof, wherein the insertion disrupts the function of an endogenous ADAM6 protein, and wherein the disruption of the endogenous ADAM6 function is associated with a reduction in fertility in male mice;
A method for modifying an immunoglobulin heavy chain locus of a mouse, comprising:
Dependencies are inferred from the claim text.